TipRanks
Go Ultimate55% OFF

Lantern Pharma (LTRN) Balance Sheet

Lantern Pharma Balance Sheet

Lantern Pharma's total assets for Q2 2026 were $8.60M, an increase of 19.10% from the previous quarter. LTRN total liabilities were $11.82M for the fiscal quarter, a 212.91% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 11.04M$ 25.57M$ 43.65M$ 58.84M$ 73.95M
$ 4.50M$ 4.38M$ 2.74M$ 2.80M$ 2.38M
$ 6.53M$ 21.19M$ 40.91M$ 56.04M$ 71.57M

Currency in USD

Lantern Pharma Debt to Assets

030M60M90M0 %60 %120 %180 %LiabilitiesDebt to Assets20182019202020212022202320242025AssetsLiabilitiesDebt to Assets